Sakurada A, Suzuki A, Sato M, Yamakawa H, Orikasa K, Uyeno S, Ono T, Ohuchi N, Fujimura S, Horii A
Department of Molecular Pathology, Tohoku University School of Medicine, Sendai.
Jpn J Cancer Res. 1997 Nov;88(11):1025-8. doi: 10.1111/j.1349-7006.1997.tb00324.x.
In the present study, we searched for genetic alterations of the entire coding region of PTEN/MMAC1, a recently isolated candidate tumor suppressor gene, in 178 specimens from Japanese patients with various malignant tumors by the polymerase chain reaction-single strand conformation polymorphism method. The samples consisted of 11 glioblastoma multiformes (GBMs), 14 astrocytomas, 47 breast cancers, 25 non-small cell lung cancers, 9 small cell lung cancers, 8 pancreatic cancers, 24 renal cell carcinomas, 20 ovarian cancers, and 20 metastatic lung tumors from various organs. Only one somatic frameshift mutation at codon 319 was observed in one (9%) of eleven GBMs. Our results suggest that mutation of the PTEN/MMAC1 gene does not play a major role in carcinogenesis, at least in the tumor types from Japanese patients analyzed in this study.
在本研究中,我们采用聚合酶链反应-单链构象多态性方法,对178例来自日本各种恶性肿瘤患者的标本,检测了最近分离出的候选抑癌基因PTEN/MMAC1整个编码区的基因改变。样本包括11例多形性胶质母细胞瘤(GBM)、14例星形细胞瘤、47例乳腺癌、25例非小细胞肺癌、9例小细胞肺癌、8例胰腺癌、24例肾细胞癌、20例卵巢癌以及20例来自不同器官的肺转移瘤。在11例GBM中的1例(9%)中仅观察到1个密码子319处的体细胞移码突变。我们的结果表明,PTEN/MMAC1基因的突变在致癌过程中不发挥主要作用,至少在本研究分析的日本患者的肿瘤类型中如此。